Overview
Announcements

Ordinary Rebalance | Solactive Genomics Index | Effective Date 16th May 2022

Solactive Genomics Index:

In the ordinary rebalancing effective open May 16, 2022 the following index composition was implemented:

2SEVENTY BIO INC-W/I 1.0424 %
AGILENT TECHNOLOGIES INC 4.4057 %
ALLOGENE THERAPEUTICS INC 1.2579 %
ALNYLAM PHARMACEUTICALS INC 3.5454 %
ARROWHEAD PHARMACEUTICALS INC 3.3023 %
BEAM THERAPEUTICS INC 3.8653 %
BIOMARIN PHARMACEUTICAL INC 4.2034 %
BIONANO GENOMICS INC 1.099 %
BIONTECH SE 4.7759 %
BLUEBIRD BIO INC 0.5907 %
CAREDX INC 3.2606 %
CARIBOU BIOSCIENCES INC 1.0232 %
CELLECTIS SA 0.3416 %
CRISPR THERAPEUTICS AG 4.3655 %
CUREVAC BV 2.0808 %
EDITAS MEDICINE INC 1.9337 %
FULGENT GENETICS INC 2.7434 %
GENSCRIPT BIOTECH CORP 4.0913 %
GILEAD SCIENCES INC 2.199 %
ILLUMINA INC 1.7045 %
INTELLIA THERAPEUTICS INC 4.2778 %
INVITAE CORP 2.3184 %
MODERNA INC 2.1025 %
MYRIAD GENETICS INC 4.0995 %
NANOSTRING TECHNOLOGIES INC 1.7809 %
NATERA INC 4.1007 %
PACIFIC BIOSCIENCES OF CALIFORNIA INC 3.0566 %
QIAGEN NV 4.4225 %
REGENXBIO INC 1.8049 %
ROCKET PHARMACEUTICALS INC 1.3019 %
SANGAMO THERAPEUTICS INC 1.1682 %
SAREPTA THERAPEUTICS INC 3.8717 %
SORRENTO THERAPEUTICS INC 1.0972 %
STOKE THERAPEUTICS INC 0.6351 %
TAKARA BIO INC 1.6906 %
ULTRAGENYX PHARMACEUTICAL INC 3.1492 %
UNIQURE B.V. 1.4237 %
VERACYTE INC 3.0422 %
VERTEX PHARMACEUTICALS INC 2.0046 %
VERVE THERAPEUTICS INC 0.8205 %